Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDMO
CRO
Charles River to close Maryland CDMO site, lay off 20 staffers
“After a thoughtful review, we determined that our cell therapy facility in Hanover, MD, is not a strategic fit,” a spokesperson told Fierce.
Will Maddox
Feb 3, 2026 12:20pm
Charles River's incoming CEO talks R&D processes, reorg goals
Jan 28, 2026 12:58pm
Fierce Pharma
WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
Dec 4, 2025 8:55am
WuXi sharpens focus by selling off clinical research units
Oct 28, 2025 12:27pm
Lonza to buy rapid microbial testing firm Redberry SAS
Oct 28, 2025 5:15am
Almac sets aside $48M to launch new trial coordinator platform
Oct 14, 2025 9:00am
